Centro de Alergia y Enfermedades Respiratorias - Buenos Aires

Centro de Alergia y Enfermedades Respiratorias - Buenos Aires
Luis María Drago 250, CABA, Buenos Aires
Select an option

Our team

Medical staff
Alberto Jorge Tolcachier
Tania Zarowsky
Hugo Daniel Tedesco
Hernán Piza
Melina Verena Heinze

Open studies

Asthma
A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma - Novartis PharmaceuticalsSee more
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma. - EXHALE-2 - Areteia TherapeuticsSee more
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS) - Regeneron PharmaceuticalsSee more
Urticaria
24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up - CLOU064F12301 - Novartis PharmaceuticalsSee more
A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines - Novartis PharmaceuticalsSee more
Chronic obstructive pulmonary disease
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease - THARROS - AstraZenecaSee more
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy